MannKind Management

Management criteria checks 3/4

MannKind's CEO is Michael Castagna, appointed in May 2017, has a tenure of 7.58 years. total yearly compensation is $7.07M, comprised of 9.9% salary and 90.1% bonuses, including company stock and options. directly owns 0.83% of the company’s shares, worth €13.13M. The average tenure of the management team and the board of directors is 7.4 years and 4.8 years respectively.

Key information

Michael Castagna

Chief executive officer

US$7.1m

Total compensation

CEO salary percentage9.9%
CEO tenure7.6yrs
CEO ownership0.8%
Management average tenure7.4yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Michael Castagna's remuneration changed compared to MannKind's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$22m

Jun 30 2024n/an/a

US$12m

Mar 31 2024n/an/a

US$8m

Dec 31 2023US$7mUS$702k

-US$12m

Sep 30 2023n/an/a

-US$31m

Jun 30 2023n/an/a

-US$47m

Mar 31 2023n/an/a

-US$71m

Dec 31 2022US$4mUS$623k

-US$87m

Sep 30 2022n/an/a

-US$98m

Jun 30 2022n/an/a

-US$88m

Mar 31 2022n/an/a

-US$94m

Dec 31 2021US$4mUS$598k

-US$81m

Sep 30 2021n/an/a

-US$79m

Jun 30 2021n/an/a

-US$86m

Mar 31 2021n/an/a

-US$61m

Dec 31 2020US$4mUS$495k

-US$57m

Sep 30 2020n/an/a

-US$45m

Jun 30 2020n/an/a

-US$44m

Mar 31 2020n/an/a

-US$46m

Dec 31 2019US$2mUS$511k

-US$52m

Sep 30 2019n/an/a

-US$47m

Jun 30 2019n/an/a

-US$61m

Mar 31 2019n/an/a

-US$71m

Dec 31 2018US$2mUS$500k

-US$87m

Sep 30 2018n/an/a

-US$110m

Jun 30 2018n/an/a

-US$119m

Mar 31 2018n/an/a

-US$131m

Dec 31 2017US$1mUS$459k

-US$117m

Compensation vs Market: Michael's total compensation ($USD7.07M) is above average for companies of similar size in the German market ($USD1.52M).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.


CEO

Michael Castagna (47 yo)

7.6yrs

Tenure

US$7,068,114

Compensation

Dr. Michael E. Castagna, Pharm D., has been Chief Executive Officer of MannKind Corporation since May 25, 2017. Dr. Castagna served as Chief Commercial Officer of MannKind Corporation since March 14, 2016...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Castagna
CEO & Director7.6yrsUS$7.07m0.83%
€ 13.1m
Lauren Sabella
Chief Operating Officer1.8yrsUS$2.74m0.025%
€ 402.4k
David Thomson
Executive VP22.9yrsUS$2.34m0.17%
€ 2.6m
Stuart Tross
Executive VP and Chief People & Workplace Officer8yrsUS$2.22m0.22%
€ 3.4m
Christopher Prentiss
Chief Financial Officerless than a yearno datano data
Sanjay Singh
Executive Vice President of Technical Operations2.2yrsUS$1.12m0.035%
€ 547.1k
Rosabel Alinaya
VP of Investor Relations & Treasury7.4yrsUS$519.59kno data
John Bedard
Senior Vice President of Worldwide Regulatory Affairs19.2yrsno datano data
James McCauley
Chief Commercial Officer7.4yrsUS$921.51kno data
Burkhard Blank
Executive VP of Research & Development and Chief Medical Officer1.6yrsno data0.070%
€ 1.1m

7.4yrs

Average Tenure

58yo

Average Age

Experienced Management: NNFN's management team is seasoned and experienced (7.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michael Castagna
CEO & Director7.6yrsUS$7.07m0.83%
€ 13.1m
Ronald Consiglio
Independent Director21.2yrsUS$241.73k0.043%
€ 677.6k
Kent Kresa
Chairman Emeritusless than a yearUS$240.64k0.096%
€ 1.5m
Christine Ann Mundkur
Independent Director6.1yrsUS$226.73k0.010%
€ 158.4k
Michael Friedman
Independent Director21yrsUS$229.23k0.0054%
€ 85.5k
Anthony Hooper
Independent Director4.9yrsUS$233.14k0.064%
€ 1.0m
James Shannon
Independent Chairman9.6yrsUS$255.64k0.0089%
€ 140.0k
Sabrina Kay
Independent Director4yrsUS$221.73k0.039%
€ 612.4k
Thomas Blevins
Member of Scientific Advisory Board3.3yrsno datano data
Steven Binder
Directorless than a yearUS$2.34m0.20%
€ 3.1m
Jennifer Grancio
Independent Director4.8yrsUS$221.73k0.040%
€ 633.4k
Davida Kruger
Member of Scientific Advisory Board3.3yrsno datano data

4.8yrs

Average Tenure

64.5yo

Average Age

Experienced Board: NNFN's board of directors are considered experienced (4.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 13:14
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MannKind Corporation is covered by 26 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas RussoBaird
Stephen V. ByrneBofA Global Research
null nullBTIG